Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Current Assets (2016 - 2025)

Icu Medical's Current Assets history spans 17 years, with the latest figure at $1.2 billion for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 17.44% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Dec 2025, down 17.44%, and an annual FY2025 reading of $1.2 billion, down 17.44% over the prior year.
  • Current Assets for Q4 2025 was $1.2 billion at Icu Medical, down from $1.2 billion in the prior quarter.
  • The five-year high for Current Assets was $1.4 billion in Q4 2024, with the low at $928.2 million in Q1 2021.
  • Average Current Assets over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2022.
  • Year-over-year, Current Assets increased 26.48% in 2022 and then decreased 17.44% in 2025.
  • Tracing ICUI's Current Assets over 5 years: stood at $1.0 billion in 2021, then increased by 19.94% to $1.2 billion in 2022, then dropped by 1.13% to $1.2 billion in 2023, then rose by 18.07% to $1.4 billion in 2024, then decreased by 17.44% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Current Assets are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025).